The Future of Falsified and Substandard Medicine Detection: Digital Methods To Track and Authenticate Pharmaceutical Products
This case study and associated publications (Naughton et al., 2017, 2016) paint a picture of a technically sound, planned digital solutions to address the problem presented by substandard and falsified medicines, which appear to be growing internationally, particularly as purchases increasingly take...
Autor principal: | Naughton, B |
---|---|
Formato: | Record |
Publicado em: |
Pathways for Prosperity Commission
2018
|
Registros relacionados
-
Trade in substandard and falsified medicines
por: Hagen, N, et al.
Publicado em: (2022) -
Substandard and Falsified Medicines in Myanmar
por: Mirai Sakuda, et al.
Publicado em: (2020-03-01) -
Identification of substandard and falsified medicines: influence of different tolerance limits and use of authenticity inquiries
por: Hauk, C, et al.
Publicado em: (2021) -
How to achieve international action on falsified and substandard medicines.
por: Attaran, A, et al.
Publicado em: (2012) -
Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance
por: Elizabeth Pisani, et al.
Publicado em: (2021-08-01)